# MUCOMMUNE, LLC: SBIR: In vivo engineering of dual CD19/CD138 CAR-T cells for treatment of Systemic Lupus Erythematosus

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | MUCOMMUNE, LLC |
| Location | Morrisville, NC |
| Project | SBIR: In vivo engineering of dual CD19/CD138 CAR-T cells for treatment of Systemic Lupus Erythematosus |
| Project number | 1R44AI197810-01 |
| Mechanism | R44 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $1,006,467 |
| Awarded | 2026-09-11 |
| Project period | 2026-09-11 to 2029-08-31 |
| UEI | NWVPL2L4JMN8 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11316654). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.